AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /EINPresswire.com/ -- The rapidly growing colon targeting drug delivery market is anticipated to witness substantial growth over the forthcoming years. The market size was projected to increase from $1.39 billion in 2024 to $1.51 billion in 2025, demonstrating a compound annual growth rate CAGR of 8.5%. The surge in growth during this historic period can be credited to the increasing occurrence of colorectal diseases, an enhanced focus on localized drug delivery, the demand for improved patient compliance, and the emergence of biologics and peptides.
Can The Robust Growth Continue In The Coming Years Of Colon Targeting Drug Delivery Market?
Indisputably, the colon-targeting drug delivery market is forecasted to see strong growth in the near future. By 2029, the market is projected to reach an impressive $2.07 billion at a compound annual growth rate CAGR of 8.3%. The anticipated growth spurt within the forecast period can be attributed to the advent of stimuli-responsive and nanotechnology-based delivery systems, expansion in contract research and manufacturing services, regulatory bodies offering attractive incentives and expedited approval pathways, and targeted delivery of biologics and biosimilars. Global trends during the same phase encompass advancements in pH-responsive and personalized medicine integration, the incorporation of AI and digital tools in formulation design, and a growing emphasis on oral colon delivery.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24194&type=smp
What Are The Market Drivers In The Colon Targeting Drug Delivery Market?
The escalating prevalence of gastrointestinal diseases is expected to stimulate the growth of the global colon targeting drug delivery market. Gastrointestinal ailments refer to disorders impacting the digestive tract, inclusive of the stomach, intestines, and interconnected organs. The rising incidence of these diseases is primarily attributed to detrimental dietary habits, like overindulgence in processed foods and low fiber intake, which significantly disrupt gut health and digestion. Colon targeting drug delivery is utilized in treating gastrointestinal disorders to ensure precision in drug release at the inflammation or infection site, thereby enhancing therapeutic effectiveness and mitigating systemic side effects.
Who Are The Key Players In The Colon Targeting Drug Delivery Market?
Major companies spearheading the colon targeting drug delivery market include Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Lonza Pharma AG, Ferring Pharmaceuticals Company Limited, Salix Pharmaceuticals Ltd., Tillotts Pharma AG, BDD Pharma Ltd., Tharimmune Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/colon-targeting-drug-delivery-global-market-report
What's Trending In The Colon Targeting Drug Delivery Market?
Major corporations in the colon targeting drug delivery market are concentrating on developing breakthrough drug delivery solutions, like functional oral dosage forms. These formats aim to increase targeted drug release, boost therapeutic efficiency, and reduce adverse effects. Functional oral dosage forms are employed in colon targeting drug delivery to safeguard active pharmaceutical ingredients from degradation in the upper gastrointestinal tract and ensure their controlled release specifically in the colon.
What Is The Market Segmentation In The Colon Targeting Drug Delivery Market?
The colon targeting drug delivery market is fragmented on the basis of:
1 Dosage Form: Tablets, Capsules, Microspheres, Nanoparticles, Other Dosage Forms
2 Technology: pH-Sensitive Systems, Time-Dependent Systems, Microbially Triggered Systems, Pressure-Controlled Systems, Other Technologies
3 Application: Inflammatory Bowel Disease, Colorectal Cancer, Infectious Diseases, Other Applications
4 End-User: Hospitals, Clinics, Research Institutes, Other End-Users
What Do The Regional Insights Suggest In The Colon Targeting Drug Delivery Market?
North America dominated the colon targeting drug delivery market in 2024. However, Asia-Pacific is expected to witness the fastest growth in the subsequent years. The regions extensively covered in the market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse through more similar reports by The Business Research Company:
Drugs for Immunotherapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Acne Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report
Drugs For Erectile Dysfunction Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report
About The Business Research Company:
The Business Research Company boasts a repertoire of over 15000+ reports from 27 industries spanning 60+ geographies, earning a reputation for delivering comprehensive, data-rich research, and actionable insights. Armed with 1,500,000 datasets, and the valuable inputs of industry leaders, The Business Research Company extracts insights that can put you ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
